PPIA and endometrial carcinoma: Li et.al using proteomics first report cyclophilin A upregulated in endometrial carcinoma serve as a potential prognostic factor [9], and up-regulation of cyclophilin A could render resistance to chemotherapeutic-induced apoptosis in cancer cells [10].